2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Neoplasms
7
Venous Thromboembolism
3
Venous Thrombosis
2
Thrombosis
2
Thromboembolism
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Sarcoma, Alveolar Soft Part
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Prostate Cancer Patients
1
Pneumonia
1
Pharmacokinetics of MDV3100
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Interventions
Dalteparin
12
apixaban
9
Enoxaparin
8
Tinzaparin
6
edoxaban
5
Rivaroxaban
5
Heparin, Low-Molecular-Weight
4
Fondaparinux
3
Dabigatran
3
bemiparin
2
abelacimab
2
Warfarin
2
Nadroparin
2
MAA868
2
Heparin
2
reviparin
1
myotubularin
1
isoquercitrin
1
certoparin
1
calcium heparin
1
atezolizumab
1
acarboxyprothrombin
1
Ultrasonography, Doppler, Duplex
1
Rosuvastatin Calcium
1
Phenprocoumon
1
Models, Biological
1
Medication Therapy Management
1
Laparoscopy
1
Intermittent Pneumatic Compression Devices
1
Imaging, Three-Dimensional
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Venous Thrombosis
×
Warfarin
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled